One of the targets of the hsa-miR-142-5p isoforms is CD44, which is a tumor stem cell marker and receptor for hyaluronan, collagens, and matrix metalloproteinases in various tissues acting also as a cofactor for VEGF and FGF2 binding. This evidence concerns the gene VEGFA and neoplasm.